Tandem Diabetes Care (TNDM) Current Assets (2013 - 2026)
Tandem Diabetes Care posted quarterly Current Assets of $887.1 million for Q1 2026, up 33.71% year-on-year from $663.4 million in Q1 2025, and up 43.51% on a QoQ basis from $618.1 million in Q4 2025.
Tandem Diabetes Care (TNDM) has 14 years of Current Assets data on file, last reported at $887.1 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 33.71% year-over-year to $887.1 million; the trailing twelve-month figure through Mar 2026 stood at $887.1 million (up 33.71% YoY), and the FY2025 full-year result was $618.1 million, down 14.68% from the prior year.
- Current Assets for Q1 2026 stood at $887.1 million, up from $618.1 million in the prior quarter.
- Across five years, Current Assets topped out at $887.1 million in Q1 2026 and bottomed at $614.8 million in Q2 2025.
- The 5-year median for Current Assets is $752.8 million (2024), against an average of $747.8 million.
- The widest annual swing landed in 2025, when Current Assets fell 18.05%; it then soared 33.71% in 2026.
- A 5-year view of Current Assets shows it stood at $850.0 million in 2022, then fell by 12.0% to $748.0 million in 2023, then decreased by 3.14% to $724.5 million in 2024, then decreased by 14.68% to $618.1 million in 2025, then soared by 43.51% to $887.1 million in 2026.
- The last three Current Assets figures came in at $887.1 million (Q1 2026), $618.1 million (Q4 2025), and $616.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 24.07 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 11.45 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 4.33 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.43 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.39 Bn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | 887.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 887.10 Mn |
| Dec 31, 2025 | 618.14 Mn |
| Sep 30, 2025 | 616.94 Mn |
| Jun 30, 2025 | 614.82 Mn |
| Mar 31, 2025 | 663.44 Mn |
| Dec 31, 2024 | 724.49 Mn |
| Sep 30, 2024 | 752.83 Mn |
| Jun 30, 2024 | 733.39 Mn |
| Mar 31, 2024 | 735.19 Mn |
| Dec 31, 2023 | 747.99 Mn |
| Sep 30, 2023 | 758.14 Mn |
| Jun 30, 2023 | 764.30 Mn |
| Mar 31, 2023 | 757.92 Mn |
| Dec 31, 2022 | 849.98 Mn |
| Sep 30, 2022 | 834.30 Mn |
| Jun 30, 2022 | 835.04 Mn |
| Mar 31, 2022 | 818.46 Mn |
| Dec 31, 2021 | 811.52 Mn |
| Sep 30, 2021 | 754.95 Mn |
| Jun 30, 2021 | 698.29 Mn |
| Mar 31, 2021 | 661.70 Mn |
| Dec 31, 2020 | 637.24 Mn |
| Sep 30, 2020 | 592.29 Mn |
| Jun 30, 2020 | 539.68 Mn |
| Mar 31, 2020 | 280.87 Mn |
| Dec 31, 2019 | 276.14 Mn |
| Sep 30, 2019 | 246.60 Mn |
| Jun 30, 2019 | 213.16 Mn |
| Mar 31, 2019 | 186.03 Mn |
| Dec 31, 2018 | 187.89 Mn |
| Sep 30, 2018 | 162.67 Mn |
| Jun 30, 2018 | 128.34 Mn |
| Mar 31, 2018 | 114.34 Mn |
| Dec 31, 2017 | 64.16 Mn |
| Sep 30, 2017 | 55.99 Mn |
| Jun 30, 2017 | 65.13 Mn |
| Mar 31, 2017 | 79.93 Mn |
| Dec 31, 2016 | 92.09 Mn |
| Sep 30, 2016 | 70.99 Mn |
| Jun 30, 2016 | 90.88 Mn |
| Mar 31, 2016 | 102.57 Mn |
| Dec 31, 2015 | 106.98 Mn |
| Sep 30, 2015 | 110.92 Mn |
| Jun 30, 2015 | 124.06 Mn |
| Mar 31, 2015 | 139.15 Mn |
| Dec 31, 2014 | 90.75 Mn |
| Sep 30, 2014 | 101.05 Mn |
| Jun 30, 2014 | 114.42 Mn |
| Mar 31, 2014 | 128.36 Mn |
| Dec 31, 2013 | 148.99 Mn |